Aslani, Rizabel .
HRN: 21-79-71 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2023
CEFTRIAXONE 1G (VIAL)
01/05/2023
01/12/2023
IV DRIP
2grams
Q24H
UTI
Waiting Final Action
04/04/2023
CEFUROXIME 500MG (TAB)
04/04/2023
04/10/2023
PO
500mg
BID
UTI
Waiting Final Action